New Drugs for Malignancy, an Issue of Hematology/oncology Clinics of North America, Vol. 26-3

Description

Topics include: Targeting IGF-1R, Tyrosine Kinase Inhibitors in Lung Cancer, Targeting mTOR, Targeting Hedgehog, Mitotic Inhibitors, Topoisomerase I Inhibitors , and New Strategies and Drugs Inhibiting Folate Pathways.

Author Info

By Franco Muggia, MD